Glenn David - 09 Feb 2025 Form 4 Insider Report for PHIBRO ANIMAL HEALTH CORP (PAHC)

Role
Chief Financial Officer
Signature
/s/ Judith Weinstein, as Attorney-in-Fact for Glenn David
Issuer symbol
PAHC
Transactions as of
09 Feb 2025
Net transactions value
$0
Form type
4
Filing time
11 Feb 2025, 16:15:14 UTC
Previous filing
09 Feb 2024
Next filing
19 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PAHC Class A Common Stock Options Exercise +30,000 30,000 09 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PAHC Restricted Stock Units Options Exercise $0 -30,000 -10% $0.000000 270,000 09 Feb 2025 Class A Common Stock 30,000 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were issued in settlement of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. No shares of Class A Common Stock were transferred or sold upon the vesting of the RSUs listed in Table II and the reporting person will pay the related tax withholding obligations in cash.
F2 On February 9, 2024 (the "Grant Date"), the reporting person was granted 300,000 RSUs pursuant to the Issuer's 2008 Incentive Plan and an RSU award agreement (the "Award Agreement").
F3 Pursuant to the Award Agreement, (i) 150,000 RSUs are subject to time vesting (collectively, the "Time Vesting RSUs") and vest in equal installments on each of the first five anniversaries of the Grant Date, subject to continued service through each such vesting date, and (ii) 150,000 RSUs are subject to performance vesting (collectively, the "Performance Vesting RSUs") and vest (with linear interpolation to apply for achievement between increments) based upon achievement of the arithmetic average of Phibro Animal Health Corporation's closing stock price per share for each trading day in the 90-calendar day period ending five years from the Grant Date, from $20 to $60 and above, subject to Mr. David's continued employment on such date. Time Vesting RSUs and Performance Vesting RSUs, in each case, are subject to earlier vesting upon certain qualifying termination events.